314 related articles for article (PubMed ID: 21824448)
21. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).
Berger V; Gabriel AF; Sergent T; Trouet A; Larondelle Y; Schneider YJ
Toxicol Lett; 2003 Apr; 140-141():465-76. PubMed ID: 12676495
[TBL] [Abstract][Full Text] [Related]
22. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
23. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
24. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2.
Mease K; Sane R; Podila L; Taub ME
J Pharm Sci; 2012 May; 101(5):1888-97. PubMed ID: 22359351
[TBL] [Abstract][Full Text] [Related]
25. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
26. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
27. The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A
Fei Z; Hu M; Baum L; Kwan P; Hong T; Zhang C
Xenobiotica; 2020 Mar; 50(3):354-362. PubMed ID: 31132291
[TBL] [Abstract][Full Text] [Related]
28. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.
Vadlapatla RK; Vadlapudi AD; Kwatra D; Pal D; Mitra AK
Int J Pharm; 2011 Nov; 420(1):26-33. PubMed ID: 21864659
[TBL] [Abstract][Full Text] [Related]
29. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
Hu M; Chen J
Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
[TBL] [Abstract][Full Text] [Related]
30. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
Choi MK; Song IS
J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Cummins CL; Mangravite LM; Benet LZ
Pharm Res; 2001 Aug; 18(8):1102-9. PubMed ID: 11587480
[TBL] [Abstract][Full Text] [Related]
32. Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers.
Zhou Y; Hu W; Zhang X; Wang Y; Zhuang W; Li F; Li Q
Chem Pharm Bull (Tokyo); 2021; 69(11):1054-1060. PubMed ID: 34719586
[TBL] [Abstract][Full Text] [Related]
33. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Shaoyao Gancao Tang on function and expression of P-glycoprotein in Caco-2 cells].
Wang Y; Zhao J; Zhao Y; Li C; Yi Y; Liang A; Odd GN
Zhongguo Zhong Yao Za Zhi; 2012 Apr; 37(7):991-6. PubMed ID: 22792804
[TBL] [Abstract][Full Text] [Related]
35. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
36. Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters.
Cholkar K; Trinh HM; Vadlapudi AD; Wang Z; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2015 May; 31(4):248-55. PubMed ID: 25844889
[TBL] [Abstract][Full Text] [Related]
37. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
38. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
39. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
[TBL] [Abstract][Full Text] [Related]
40. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
